共 30 条
[1]
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 53 (04)
:942-947
[2]
Abitbol AA, 1997, CANCER-AM CANCER SOC, V80, P266, DOI 10.1002/(SICI)1097-0142(19970715)80:2<266::AID-CNCR15>3.0.CO
[3]
2-S
[4]
Abitbol AA, 1999, DYSPHAGIA SERIES, P47
[6]
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
[J].
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,
2001, 23 (07)
:579-589
[7]
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 53 (01)
:23-28
[9]
FABIAN RL, 1984, LARYNGOSCOPE, V94, P1334
[10]
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2000, 48 (01)
:7-16

